FDA Approves GE Brain Imaging Tool for Alzheimer's

By: Associated Press
By: Associated Press

WASHINGTON (AP) - The Food and Drug Administration has approved a radioactive imaging chemical from General Electric to help screen for Alzheimer's disease.

The drug, Vizamyl, is an injection of radioactive material designed to highlight abnormal brain plaque in medical imaging scans.

Dementia caused by Alzheimer's is associated with buildup of the plaque, known as beta amyloid protein. However, it can also be found in patients who do not have neurological problems.

Vizamyl works by binding to the plaque and creating images that show up on positron emission tomography, or PET, scans of the brain.

The FDA says a negative scan means there is little plaque and the cause of dementia is probably not Alzheimer's. A positive scan means the patient has at least some plaque, but does not prove they have Alzheimer's.


KBTX-TV Channel 3 4141 E. 29th Street Bryan, TX 77802 Phone: (979) 846-7777 Fax: (979) 846-1490 News Fax: (979) 846-1888
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 229308431 - kbtx.com/a?a=229308431
Gray Television, Inc.